The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1
Wylie, Andrew A., Schoepfer, Joseph, Jahnke, Wolfgang, Cowan-Jacob, Sandra W., Loo, Alice, Furet, Pascal, Marzinzik, Andreas L., Pelle, Xavier, Donovan, Jerry, Zhu, Wenjing, Buonamici, Silvia, Hassan,Том:
543
Мова:
english
Журнал:
Nature
DOI:
10.1038/nature21702
Date:
March, 2017
Файл:
PDF, 3.25 MB
english, 2017